As you age, your risk for higher blood sugar increases—which raises the risk of type 2 diabetes for adults in their 50s, 60s, and 70s. Using a chart of blood sugar levels by age can help you track ...

Supplied. In the pharmaceutical industry regulatory hurdles often derail ambitions. But a Melbourne-based Avecho Biotechnology has turned regulation to its advantage, signing a deal with ₣17 billion ...

(Bloomberg) -- Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group. The Sandoz Family Foundation, through the vehicle Emasan AG, is offering 26.5 ...

Some studies have found that increased sugar intake can have a negative effect on ADHD symptoms. However, research is mixed, and more long-term studies are needed to verify this connection.

Researchers have found that amlodipine, a common blood pressure medication, may help manage ADHD by reducing hyperactivity and impulsivity. Its ability to cross the blood-brain barrier and target ADHD ...

Basel, February 24, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announces the launch of Pyzchiva®* (ustekinumab-ttwe) in the US.

But amlodipine, which is taken daily, may even work just as well to banish hyperactivity without any significant side effects, scientists believe. The study on zebrafish — which share 70 per ...

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study. Blood pressure ...

When you have type 1 or type 2 diabetes, dangerous spikes in blood glucose (severe hyperglycemia) may mean you need to reduce blood sugar levels quickly. If you don't, you could be at risk for ...

Aspartame has long been marketed as a guilt-free alternative to sugar in popular food products, ranging from zero-calorie Diet Coke to sugar-free Jell-O. It's also had a pretty bad rap ...

High blood sugar (hyperglycemia) primarily affects people with diabetes. It occurs when your body doesn’t produce enough insulin, cannot absorb it properly, or develops a resistance to it entirely.

Feb 18 (Reuters) - Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who accused the company of conspiring with industry rivals ...